[
  {
    "ts": null,
    "headline": "NVST or ABT: Which Is the Better Value Stock Right Now?",
    "summary": "NVST vs. ABT: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=3aaf32a8246813ead83927f90f878334c4a0ba446ecb9f65ad6de93ec3f00d8b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756136403,
      "headline": "NVST or ABT: Which Is the Better Value Stock Right Now?",
      "id": 136522453,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "NVST vs. ABT: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=3aaf32a8246813ead83927f90f878334c4a0ba446ecb9f65ad6de93ec3f00d8b"
    }
  },
  {
    "ts": null,
    "headline": "If You Invested $10K In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?",
    "summary": "Abbott Laboratories (NYSE:ABT) is a global healthcare company that develops and sells a wide range of health technologies and products. It is set to report its Q3 2025 earnings on Oct. 15. Wall Street analysts expect the company to post EPS of $1.30, ...",
    "url": "https://finnhub.io/api/news?id=8d0abb579beaa2e08e1c20687d1797b79e5b55d9d18ada21e87dfead68999fea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756126166,
      "headline": "If You Invested $10K In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?",
      "id": 136508019,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) is a global healthcare company that develops and sells a wide range of health technologies and products. It is set to report its Q3 2025 earnings on Oct. 15. Wall Street analysts expect the company to post EPS of $1.30, ...",
      "url": "https://finnhub.io/api/news?id=8d0abb579beaa2e08e1c20687d1797b79e5b55d9d18ada21e87dfead68999fea"
    }
  },
  {
    "ts": null,
    "headline": "Enteral Nutrition Market Focused Insights Report 2025-2030 with Exclusive Data on 16 Vendors Including Abbott, B. Braun, Danone, Nestle, Fresenius Kabi",
    "summary": "The global enteral nutrition market is projected to grow at a CAGR of 6.78% from 2024 to 2030, driven by a rise in cancer and neurological diseases. Key market players, including Danone and Nutrisens Group, are expanding their portfolios through strategic acquisitions in Latin America and the U.S. The tube-feeding segment leads with 57% of the market share, especially in APAC, the dominant region. Driving factors include a shift from parenteral to enteral nutrition and innovations in feeding tec",
    "url": "https://finnhub.io/api/news?id=9fd82b416809aa680079db5707a6de7a3a5434c262b3eb5ca1899a5ff971cd53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756109160,
      "headline": "Enteral Nutrition Market Focused Insights Report 2025-2030 with Exclusive Data on 16 Vendors Including Abbott, B. Braun, Danone, Nestle, Fresenius Kabi",
      "id": 136508021,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The global enteral nutrition market is projected to grow at a CAGR of 6.78% from 2024 to 2030, driven by a rise in cancer and neurological diseases. Key market players, including Danone and Nutrisens Group, are expanding their portfolios through strategic acquisitions in Latin America and the U.S. The tube-feeding segment leads with 57% of the market share, especially in APAC, the dominant region. Driving factors include a shift from parenteral to enteral nutrition and innovations in feeding tec",
      "url": "https://finnhub.io/api/news?id=9fd82b416809aa680079db5707a6de7a3a5434c262b3eb5ca1899a5ff971cd53"
    }
  }
]